BALPHARMA₹81.09-4.11%
Value & Investment Index
VIIVII Detail
90 days · zone the stock traded inMultiples vs Peers
Quality Scores
Versus Its Own History
P/E · P/B percentile bandsScenario analysis
stated assumptions, shown workingsBALPHARMA valuation summary
Bal Pharma Ltd trades at 19.5 times trailing earnings. Return on equity is 6.6% and return on capital employed is 9.3%. The dividend yield is 1.29%.
| P/E | 19.5 |
|---|---|
| ROE | 6.6% |
| ROCE | 9.3% |
| Dividend yield | 1.29% |